Based on the aforementioned data, we hypothesized that, as a genetic form of AD, DS CSF will have reduced NPTX2 and correlated GluA4 levels, reflecting PV interneuron dysfunction, thus representing a potential surrogate marker of early AD pathophysiology in adults with DS. The gene discussed is NPTX2; the disease is Dravet syndrome.